Compare AZN & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MS |
|---|---|---|
| Founded | 1992 | 1924 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 344.0B |
| IPO Year | 1995 | 2025 |
| Metric | AZN | MS |
|---|---|---|
| Price | $158.44 | $218.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $337.93 |
| AVG Volume (30 Days) | 3.6M | ★ 4.4M |
| Earning Date | 04-29-2026 | 04-15-2026 |
| Dividend Yield | 1.73% | ★ 2.14% |
| EPS Growth | N/A | ★ 28.43 |
| EPS | N/A | ★ 6.90 |
| Revenue | N/A | ★ $34,275,000,000.00 |
| Revenue This Year | $10.34 | $12.22 |
| Revenue Next Year | $6.43 | $5.62 |
| P/E Ratio | $31.91 | ★ $31.17 |
| Revenue Growth | N/A | ★ 5.73 |
| 52 Week Low | $72.90 | $141.03 |
| 52 Week High | $212.71 | $232.25 |
| Indicator | AZN | MS |
|---|---|---|
| Relative Strength Index (RSI) | 36.63 | 53.71 |
| Support Level | $153.41 | $205.72 |
| Resistance Level | $175.04 | $219.16 |
| Average True Range (ATR) | 3.19 | 5.39 |
| MACD | -0.32 | 0.34 |
| Stochastic Oscillator | 23.66 | 84.97 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.